These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3013396)

  • 1. Peripheral neuropathy associated with high-dose Ara-C therapy.
    Borgeat A; De Muralt B; Stalder M
    Cancer; 1986 Aug; 58(4):852-4. PubMed ID: 3013396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.
    Kornblau SM; Cortes-Franco J; Estey E
    Leukemia; 1993 Mar; 7(3):378-83. PubMed ID: 8445943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukaemia.
    Paul M; Joshua D; Rahme N; Pollard J; Ell J; Gibson J; Bonnet D
    Br J Haematol; 1991 Nov; 79(3):521-3. PubMed ID: 1661126
    [No Abstract]   [Full Text] [Related]  

  • 5. Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
    Nevill TJ; Benstead TJ; McCormick CW; Hayne OA
    Am J Hematol; 1989 Dec; 32(4):314-5. PubMed ID: 2554727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia.
    Scherokman B; Filling-Katz MR; Tell D
    Cancer Treat Rep; 1985 Sep; 69(9):1005-6. PubMed ID: 2992782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Painful legs and moving toes. Neuropathy caused by cytarabine].
    Malapert D; Degos JD
    Rev Neurol (Paris); 1989; 145(12):869-71. PubMed ID: 2559449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.
    Thordarson H; Talstad I
    Acta Med Scand; 1986; 220(5):493-5. PubMed ID: 3468760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
    Wells RJ; Feusner J; Devney R; Woods WG; Provisor AJ; Cairo MS; Odom LF; Nachman J; Jones GR; Ettinger LJ
    J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
    Powell BL; Capizzi RL; Lyerly ES; Cooper MR
    J Clin Oncol; 1986 Jan; 4(1):95-7. PubMed ID: 3001234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
    Estey E; Plunkett W; Gandhi V; Rios MB; Kantarjian H; Keating MJ
    Leuk Lymphoma; 1993 Mar; 9(4-5):343-50. PubMed ID: 8394169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal peripheral neuropathy following FLA chemotherapy.
    Osborne WL; Holyoake TL; McQuaker IG; Parker AN
    Clin Lab Haematol; 2004 Aug; 26(4):295-6. PubMed ID: 15279668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
    Stryckmans P; De Witte T; Bitar N; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):67-72. PubMed ID: 3296209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of refractory acute lymphocytic leukemia responded to an intermediate-dose of cytosine arabinoside (ID Ara-C) therapy].
    Hirota Y; Shibuya T; Ohhara N; Okamura S; Iwagiri R; Tada Y; Otsuka T; Nagano M; Tsuda Y; Niho Y
    Rinsho Ketsueki; 1986 Jun; 27(6):941-6. PubMed ID: 3463812
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Openshaw H; Slatkin NE; Stein AS; Hinton DR; Forman SJ
    Cancer; 1996 Nov; 78(9):1899-905. PubMed ID: 8909309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic experiences with high-dose ARA-C and L-ASP].
    Dickerhoff R; Haas RJ
    Onkologie; 1985 Feb; 8(1):44-5. PubMed ID: 3885121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
    Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
    Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.
    Li R; Hu X; Wang L; Cheng H; Lv S; Zhang W; Wang J; Yang J; Song X
    Am J Hematol; 2017 Jan; 92(1):12-17. PubMed ID: 27673579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.